PMID- 35227333 OWN - NLM STAT- MEDLINE DCOM- 20220316 LR - 20220316 IS - 2047-2994 (Electronic) IS - 2047-2994 (Linking) VI - 11 IP - 1 DP - 2022 Feb 28 TI - Implementation of the Infection Risk Scan (IRIS) in nine hospitals in the Belgian-Dutch border region (i-4-1-Health project). PG - 43 LID - 10.1186/s13756-022-01083-1 [doi] LID - 43 AB - BACKGROUND: A tool, the Infection Risk Scan has been developed to measure the quality of infection control and antimicrobial use. This tool measures various patient-, ward- and care-related variables in a standardized way. We describe the implementation of this tool in nine hospitals in the Dutch/Belgian border area and the obtained results. METHODS: The IRIS consists of a set of objective and reproducible measurements: patient comorbidities, (appropriate) use of indwelling medical devices, (appropriate) use of antimicrobial therapy, rectal carriage of Extended-spectrum beta-lactamase producing Enterobacterales and their clonal relatedness, environmental contamination, hand hygiene performance, personal hygiene of health care workers and presence of infection prevention preconditions. The Infection Risk Scan was implemented by an expert team. In each setting, local infection control practitioners were trained to achieve a standardized implementation of the tool and an unambiguous assessment of data. RESULTS: The IRIS was implemented in 34 wards in six Dutch and three Belgian hospitals. The tool provided ward specific results and revealed differences between wards and countries. There were significant differences in the prevalence of ESBL-E carriage between countries (Belgium: 15% versus The Netherlands: 9.6%), environmental contamination (median adenosine triphosphate (ATP) level Belgium: 431 versus median ATP level The Netherlands: 793) and calculated hand hygiene actions based on alcohol based handrub consumption (Belgium: 12.5/day versus The Netherlands: 6.3/day) were found. CONCLUSION: The Infection risk Scan was successfully implemented in multiple hospitals in a large cross-border project and provided data that made the quality of infection control and antimicrobial use more transparent. The observed differences provide potential targets for improvement of the quality of care. CI - (c) 2022. The Author(s). FAU - Verelst, Martine AU - Verelst M AD - Department of Infection Control, University Hospital Leuven, Leuven, Belgium. martine.verelst@uzleuven.be. FAU - Willemsen, Ina AU - Willemsen I AD - Department of Infection Control, Amphia Hospital, Breda, The Netherlands. FAU - Weterings, Veronica AU - Weterings V AD - Department of Infection Control, Amphia Hospital, Breda, The Netherlands. FAU - De Waegemaeker, Pascal AU - De Waegemaeker P AD - Department of Infection Control, University Hospital Ghent, Ghent, Belgium. FAU - Leroux-Roels, Isabelle AU - Leroux-Roels I AD - Department of Infection Control, University Hospital Ghent, Ghent, Belgium. FAU - Nieuwkoop, Ellen AU - Nieuwkoop E AD - Department of Infection Control, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands. FAU - Saegeman, Veroniek AU - Saegeman V AD - Department of Infection Control, University Hospital Leuven, Leuven, Belgium. FAU - van Alphen, Lieke AU - van Alphen L AD - Departement of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center+, Maastricht, The Netherlands. FAU - van Kleef-van Koeveringe, Stefanie AU - van Kleef-van Koeveringe S AD - Laboratory of Clinical Microbiology, University Hospital Antwerp, Antwerp, Belgium. FAU - Kluytmans-van den Bergh, Marjolein AU - Kluytmans-van den Bergh M AD - Department of Infection Control, Amphia Hospital, Breda, The Netherlands. AD - Julius Center for Health Sciences and Primary Care, UMC Utrecht, University Utrecht, Utrecht, The Netherlands. FAU - Kluytmans, Jan AU - Kluytmans J AD - Department of Infection Control, Amphia Hospital, Breda, The Netherlands. AD - Julius Center for Health Sciences and Primary Care, UMC Utrecht, University Utrecht, Utrecht, The Netherlands. FAU - Schuermans, Annette AU - Schuermans A AD - Department of Infection Control, University Hospital Leuven, Leuven, Belgium. CN - i-4-1-Health study group LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220228 PL - England TA - Antimicrob Resist Infect Control JT - Antimicrobial resistance and infection control JID - 101585411 SB - IM MH - Belgium/epidemiology MH - *Cross Infection/epidemiology/prevention & control MH - *Hand Hygiene MH - Hospitals MH - Humans MH - Infection Control/methods PMC - PMC8887653 OTO - NOTNLM OT - Benchmarking OT - Guidelines OT - Infection prevention OT - Surveillance COIS- The author declare that they have no competing interests. FIR - van Alphen, Lieke IR - van Alphen L FIR - van den Braak, Nicole IR - van den Braak N FIR - Broucke, Caroline IR - Broucke C FIR - Buiting, Anton IR - Buiting A FIR - Coorevits, Liselotte IR - Coorevits L FIR - Dequeker, Sara IR - Dequeker S FIR - Dewulf, Jeroen IR - Dewulf J FIR - Dhaeze, Wouter IR - Dhaeze W FIR - Diederen, Bram IR - Diederen B FIR - Ewalts, Helen IR - Ewalts H FIR - Goossens, Herman IR - Goossens H FIR - Gyssens, Inge IR - Gyssens I FIR - den Heijer, Casper IR - den Heijer C FIR - Hoebe, Christian IR - Hoebe C FIR - Jamin, Casper IR - Jamin C FIR - Jansingh, Patricia IR - Jansingh P FIR - Kluytmans, Jan IR - Kluytmans J FIR - Kluytmans-van den Bergh, Marjolein IR - Kluytmans-van den Bergh M FIR - van Kleef-van Koeveringe, Stefanie IR - van Kleef-van Koeveringe S FIR - De Koster, Sien IR - De Koster S FIR - Lammens, Christine IR - Lammens C FIR - Leroux-Roels, Isabel IR - Leroux-Roels I FIR - Masson, Hanna IR - Masson H FIR - Nieuwkoop, Ellen IR - Nieuwkoop E FIR - Van Oosten, Anita IR - Van Oosten A FIR - Selva, Natascha Perales IR - Selva NP FIR - Postma, Merel IR - Postma M FIR - Raven, Stijn IR - Raven S FIR - Saegeman, Veroniek IR - Saegeman V FIR - Savelkoul, Paul IR - Savelkoul P FIR - Schuermans, Annette IR - Schuermans A FIR - Sleeckx, Nathalie IR - Sleeckx N FIR - van der Slikke, Krista IR - van der Slikke K FIR - Stegeman, Arjan IR - Stegeman A FIR - Tobias, Tijs IR - Tobias T FIR - Tolsma, Paulien IR - Tolsma P FIR - Veenemans, Jacobien IR - Veenemans J FIR - van der Vegt, Dewi IR - van der Vegt D FIR - Verelst, Martine IR - Verelst M FIR - Verhulst, Carlo IR - Verhulst C FIR - De Waegemaeker, Pascal IR - De Waegemaeker P FIR - Weterings, Veronica IR - Weterings V FIR - Wijkmans, Clementine IR - Wijkmans C FIR - Willemse-Smits, Patricia IR - Willemse-Smits P FIR - Willemsen, Ina IR - Willemsen I EDAT- 2022/03/02 06:00 MHDA- 2022/03/17 06:00 PMCR- 2022/02/28 CRDT- 2022/03/01 05:43 PHST- 2021/12/30 00:00 [received] PHST- 2022/02/07 00:00 [accepted] PHST- 2022/03/01 05:43 [entrez] PHST- 2022/03/02 06:00 [pubmed] PHST- 2022/03/17 06:00 [medline] PHST- 2022/02/28 00:00 [pmc-release] AID - 10.1186/s13756-022-01083-1 [pii] AID - 1083 [pii] AID - 10.1186/s13756-022-01083-1 [doi] PST - epublish SO - Antimicrob Resist Infect Control. 2022 Feb 28;11(1):43. doi: 10.1186/s13756-022-01083-1.